Iridex (IRIX) EPS (Weighted Average and Diluted) (2016 - 2026)
Iridex has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at -$0.01 for Q1 2026.
- Quarterly results put EPS (Weighted Average and Diluted) at -$0.01 for Q1 2026, up 80.0% from a year ago — trailing twelve months through Jan 2026 was -$0.26 (up 51.85% YoY), and the annual figure for FY2026 was -$0.26, up 51.85%.
- EPS (Weighted Average and Diluted) for Q1 2026 was -$0.01 at Iridex, up from -$0.09 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for IRIX hit a ceiling of $0.1 in Q1 2022 and a floor of -$0.21 in Q1 2024.
- Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.11 (2022), compared with a mean of -$0.1.
- Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 255.56% in 2022 and later surged 80.0% in 2026.
- Iridex's EPS (Weighted Average and Diluted) stood at -$0.07 in 2022, then tumbled by 157.14% to -$0.18 in 2023, then surged by 72.22% to -$0.05 in 2024, then tumbled by 80.0% to -$0.09 in 2025, then surged by 88.89% to -$0.01 in 2026.
- The last three reported values for EPS (Weighted Average and Diluted) were -$0.01 (Q1 2026), -$0.09 (Q3 2025), and -$0.06 (Q2 2025) per Business Quant data.